CAPTRUST FINANCIAL ADVISORS - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$238,426
-32.8%
138,620
-23.8%
0.00%0.0%
Q2 2023$354,771
-31.7%
181,934
-2.7%
0.00%
-50.0%
Q1 2023$519,677
-19.4%
186,9340.0%0.00%
-33.3%
Q4 2022$644,923
+34.4%
186,9340.0%0.00%0.0%
Q3 2022$480,000
+42.9%
186,934
+34.5%
0.00%
+50.0%
Q2 2022$336,000
-25.7%
138,947
+26.5%
0.00%
-33.3%
Q1 2022$452,000
-56.3%
109,800
+36.4%
0.00%
-57.1%
Q4 2021$1,035,000
+73.9%
80,500
+46.1%
0.01%
+40.0%
Q3 2021$595,000
+202.0%
55,100
+155.1%
0.01%
+150.0%
Q2 2021$197,000
+99.0%
21,600
+105.7%
0.00%
+100.0%
Q1 2021$99,000
-66.9%
10,500
-86.2%
0.00%
-75.0%
Q4 2020$299,000
-3.2%
75,884
-33.9%
0.00%
-20.0%
Q3 2020$309,000
-59.4%
114,884
-1.2%
0.01%
-61.5%
Q2 2020$761,000
+28.8%
116,254
+11.9%
0.01%0.0%
Q1 2020$591,000
+79.6%
103,854
+156.7%
0.01%
+160.0%
Q4 2019$329,00040,4540.01%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$41,970,0008.18%
Copernicus Capital Management, LLC 37,000$349,0005.64%
EcoR1 Capital, LLC 3,421,287$32,263,0001.43%
Palo Alto Investors LP 2,298,382$21,674,0001.24%
AlpInvest Partners B.V. 226,866$2,139,0001.06%
Stenahm Asset Managment Ltd 150,000$1,415,0001.00%
FRAZIER MANAGEMENT LLC 1,030,878$9,721,0000.78%
BVF INC/IL 1,861,239$17,551,0000.66%
Avidity Partners Management LP 2,122,064$20,011,0000.55%
Redmile Group, LLC 2,448,158$23,086,0000.32%
View complete list of GRITSTONE ONCOLOGY INC shareholders